Shital Tripathi, Founder & CEO of Pari Biosciences Inc. – Transforming IVF Through Womb Readiness | TiE Women’s Program Silicon Valley 2026
At the TiE Women’s Program – Silicon Valley, we spotlight women founders who are addressing important challenges and building solutions that can transform lives. Shital Tripathi, Founder & CEO of Pari Biosciences Inc., is bringing together AI and microbiome science to tackle an overlooked factor in fertility care: womb readiness.
The Problem
IVF has helped millions of people pursue their dreams of building a family, yet treatment does not always result in a successful pregnancy.
One overlooked factor is the readiness of the womb to support implantation. Womb readiness is associated with up to 60% of IVF failures, yet there are currently no approved solutions specifically designed to assess and improve it.
For patients and clinicians, this represents a significant gap in fertility care — and an opportunity for innovation.
Pari Biosciences’ Solution
Pari Biosciences is combining artificial intelligence and microbiome science to assess and improve womb readiness.
By focusing on this often-overlooked aspect of IVF, Pari Bio is working to develop a new approach to understanding the factors that influence fertility outcomes.
The company is starting with IVF, while building a proprietary data platform designed to create broader opportunities for innovation across women’s health.
Why This Matters
Women’s health has historically faced significant gaps in research, data, and innovation. Pari Biosciences is focused on one of those gaps by bringing advanced technology and scientific insight to an important challenge in fertility care.
Its work has the potential to help:
- Advance understanding of womb readiness
- Address an overlooked factor in IVF outcomes
- Combine AI and microbiome science in fertility care
- Build new data-driven approaches to women’s health
Starting with IVF, Pari Bio is building toward a broader vision: transforming women’s health through data, science, and technology.
About the Founder
Shital Tripathi, Founder & CEO of Pari Biosciences Inc., is building a company at the intersection of AI, microbiome science, fertility, and women’s health.
Through Pari Bio, she is tackling a complex and underserved challenge in IVF and developing a platform designed to unlock new possibilities across women’s health.
Her vision reflects what the TiE Women’s Program champions — women founders identifying critical challenges, developing innovative solutions, and building companies with the potential to create meaningful impact.
Powered by TiE Women – Silicon Valley
The TiE Women’s Program supports women founders through:
- Expert-led masterclasses
- 1:1 mentorship
- Access to investors and industry networks
- Pitch preparation and opportunities
- Local and global connections
Through the program, founders gain the knowledge, connections, and platform to take their businesses to the next level.
Because when women founders build, entire ecosystems move forward.
Watch Shital’s Pitch
👉 Watch Shital Tripathi pitch Pari Biosciences’ vision at the TiE Women’s Silicon Valley Finals:
Learn more about Pari Biosciences Inc.:
www.paribiosciences.com